Retention of CD34(+) CML stem/progenitor cells during imatinib treatment and rapid decline after treatment with second-generation BCR–ABL inhibitors

por Minami, Y, Abe, A, Minami, M, Kitamura, K, Hiraga, J, Mizuno, S, Ymamoto, K, Sawa, M, Inagaki, Y, Miyamura, K, Naoe, T
Publicado 2012